Takara Bio
Takara Bio is committed to improving the human condition through biotechnology. Starting as the biomedical business of Takara Shuzo, a fermentation and beverage company founded in 1925, Takara Bio has focused on developing research tools for the life sciences, cell and gene therapy technologies and nutraceuticals since its launch in 1967.
Latest Content
Product News
Takara Bio USA Holdings, Inc. Announces the Acquisition of Curio Bioscience, Adding Spatial Biology to Its Broad Portfolio of Single-Cell Omics Solutions
Takara Bio USA Holdings, Inc. (”TBUSH”) announced the acquisition of Curio Bioscience. This strategic acquisition combines two innovative spatial biology platforms with Takara Bio’s portfolio of single-cell genomics tools.
Product News
Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS
Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®.
Product News
Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine
Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Product News
Takara Bio Announces Partnership for the Distribution of CE-IVD Solutions for Respiratory Tract Infections
Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Advertisement
